Consonance Capital Management LP Iovance Biotherapeutics, Inc. Transaction History

Consonance Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $12.9 Million - $26.1 Million	-790,197 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $26.4 Million - $48.4 Million	-920,606 Reduced 53.81%	790,197 $25 Million
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $48 Million - $86 Million	1,710,803 New	1,710,803 $79.4 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $29.5 Million - $58.6 Million	-1,509,327 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$17.95 - $29.41 $3.05 Million - $5 Million	-170,000 Reduced 10.12%	1,509,327 $41.8 Million
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $75.1 Million - $109 Million	-4,173,509 Reduced 71.31%	1,679,327 $30.6 Million
Q2 2019 Aug 14, 2019	BUY	$9.78 - $24.52 $46.1 Million - $116 Million	4,712,836 Added 413.41%	5,852,836 $144 Million
Q1 2019 May 15, 2019	BUY	$8.41 - $11.26 $9.59 Million - $12.8 Million	1,140,000 New	1,140,000 $10.8 Million
Q2 2018 Aug 14, 2018	SELL	$12.45 - $16.95 $39.9 Million - $54.3 Million	-3,206,073 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $24.1 Million - $58 Million	2,973,677 Added 1279.57%	3,206,073 $54.2 Million
Q4 2017 Feb 14, 2018	BUY	$6.65 - $9.25 $1.55 Million - $2.15 Million	232,396	232,396 $1.86 Million

313

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.